Valeo Pharma Stock Probability of Future Pink Sheet Price Finishing Over 0.0469
| VPHIF Stock | USD 0.05 0.00 0.00% |
Valeo |
Valeo Pharma Target Price Odds to finish over 0.0469
The tendency of Valeo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.05 | 90 days | 0.05 | about 61.25 |
Based on a normal probability distribution, the odds of Valeo Pharma to move above the current price in 90 days from now is about 61.25 (This Valeo Pharma probability density function shows the probability of Valeo Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Valeo Pharma has a beta of -0.61. This entails as returns on the benchmark increase, returns on holding Valeo Pharma are expected to decrease at a much lower rate. During a bear market, however, Valeo Pharma is likely to outperform the market. Additionally Valeo Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Valeo Pharma Price Density |
| Price |
Predictive Modules for Valeo Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Valeo Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Valeo Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Valeo Pharma is not an exception. The market had few large corrections towards the Valeo Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Valeo Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Valeo Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.7 | |
β | Beta against Dow Jones | -0.61 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.14 |
Valeo Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Valeo Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Valeo Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Valeo Pharma generated a negative expected return over the last 90 days | |
| Valeo Pharma has high historical volatility and very poor performance | |
| Valeo Pharma has some characteristics of a very speculative penny stock | |
| Valeo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.75 M. Net Loss for the year was (25.75 M) with profit before overhead, payroll, taxes, and interest of 8.52 M. | |
| Valeo Pharma has accumulated about 27.72 M in cash with (28.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company outstanding shares are owned by insiders |
Valeo Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Valeo Pink Sheet often depends not only on the future outlook of the current and potential Valeo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Valeo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.2 M |
Valeo Pharma Technical Analysis
Valeo Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Valeo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Valeo Pharma. In general, you should focus on analyzing Valeo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Valeo Pharma Predictive Forecast Models
Valeo Pharma's time-series forecasting models is one of many Valeo Pharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Valeo Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Valeo Pharma
Checking the ongoing alerts about Valeo Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Valeo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Valeo Pharma generated a negative expected return over the last 90 days | |
| Valeo Pharma has high historical volatility and very poor performance | |
| Valeo Pharma has some characteristics of a very speculative penny stock | |
| Valeo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.75 M. Net Loss for the year was (25.75 M) with profit before overhead, payroll, taxes, and interest of 8.52 M. | |
| Valeo Pharma has accumulated about 27.72 M in cash with (28.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company outstanding shares are owned by insiders |
Other Information on Investing in Valeo Pink Sheet
Valeo Pharma financial ratios help investors to determine whether Valeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valeo with respect to the benefits of owning Valeo Pharma security.